Advanced Search
Contact | Corporate | Help

Daily news email for April 02, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Biotage Unveils Isolera (TM) Spektra with Full PDA Spectral Scanning

Results of Letermovir (AIC246) Phase 2b in Prophylaxis of Human Cytomegalovirus in Recipients ...

BioRN Annual Conference 2012: Mobilizing Seed and Venture Capital for Health Innovation

Cellmid Launches Évolis (TM) Hair Products

LingVitae, Plarion and KTH Royal Institute of Technology Initiate a Collaboration to Provide ...

 BioSpace
AVI BioPharma, Inc.: Eteplirsen Study Shows No Significant Improvement in Walking

Keryx Biopharmaceuticals, AEterna Zentaris Colorectal Cancer Drug Fails Trial

Sources: Roche May Drop Its Offer for Illumina, Inc.

Pharmaceutical Giant Aurobindo Pharma Named in Corruption Probe

AVI BioPharma, Inc.: Eteplirsen Study Shows No Significant Improvement in Walking; Stock Falls -Down 0.35(22.73%) @ 10:54AM EDT

BioSpace - Breaking News
Oncolytics Biotech Inc. Completes Enrollment in First Stage of Phase III Study in Head and Neck Cancers

Astellas Pharma Europe Release: New Data Demonstrates DIFICLIR May Offer Benefits for Cancer Patients, who are at High Risk of Clostridium Difficile Infection

Raptor Pharmaceutical Inc. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis

Trius Therapeutics' Antibiotic Tedizolid Demonstrates High Efficacy in Patients With Cellulitis

VaxInnate Corporation Names as its New CEO

Biotech News - Business Wire
PerkinElmer Launches HER2Sense Discovery Research Imaging Agent to Enable Personalized Medicine Approaches for Breast Cancer Research

Fibrocell Science, Inc. Reschedules Fourth Quarter 2011 Business Update Investor Conference Call for Tuesday, April 3, at 8:00 AM Eastern Time

Wisconsin Economic Development Corporation, Marshfield Clinic and BioForward offer Small Business Scholarships to Attend 2012 BIO International Convention

Illumina's Board Unanimously Rejects Roche's Revised Unsolicited Offer

Rockland Immunochemicals Develops Antibodies Involved in Cell Signaling Through a Unique Partnership

 Biotech News - PR Newswire
American Regent Initiates Nationwide Voluntary Recall of Cyanocobalamin Injection, USP, 1000 mcg/mL, 1mL Vial Lot #s 1662, 1679, 1683 Due to Cracks in the Vials

Verenium Announces Full Retirement of $35 Million in Debt

Organovo Reports 2011 Financial Results

Biotech Market Analysis Forecasts Rapid Growth in Mesenchymal Stem Cell Research

UCB Shines a Spotlight on the Trials and Triumphs of Living with Epilepsy with the "My Four Words" Project
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
US Protests India's Compulsory License for Nexavar

Nanotech Armor Guards Against Breast Cancer Remission

FDA Approves Affymax Anemia Therapy

New Guidelines on Taking Life's Measure

Bausch & Lomb to Buy Ista Pharmaceuticals

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Metamark Genetics Completes Proof-of-Concept for Protein-based Prostate Cancer Test

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Density Mobile Storage Systems

TYRX CITADEL/CENTURION Clinical Studies Enroll 1000th Patient

BioClinica Partners with Mirada Medical for New Era of Molecular Image Analysis in Clinical Trials

Lantheus Medical Imaging to Host Fourth Quarter/2011 Conference Call on April 5, 2012 at 4:00 p.m. Eastern Time

 Clinical Trials - PR Newswire
Not All Infant Bronchiolitis Is The Same

Original Research From RMANJ Has Broad-Reaching Implications for Improving Success in IVF

Sangamo BioSciences Announces Publication in Nature Medicine Demonstrating Use of ZFN Technology to Engineer Safer and More Effective Cancer Treatments

Nektar Doses First Subjects in Phase 1 Clinical Study Evaluating NKTR-192, a New Short-Acting Opioid Molecule for the Treatment of Acute Pain

Boston Scientific Launches Innovative Device Used to Prevent Stone Migration in Urologic Procedures

 CNN Top Stories
Obama to justices: Mandate is needed

Florida prosecutor rips 'outright lies'

GSA head resigns over Vegas seminar

Police: 7 people shot dead at California religious college

U.S. hails Suu Kyi's win in Myanmar
Contract Pharma
CRL Enhances Presence in South America

GSK Increases Stake in Theravance

Ablynx Earns Novartis Milestone

CenterWatch Study Shows Signs of Clinical Recovery

Sunesis, Royalty Pharma in Vosaroxin Pact

 FDA Drugs- What's New
FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses

Postmarketing Requirements and Commitments: Reports

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

 FDA News - Business Wire
GenMark Diagnostics Appoints Richard B. Slansky Chief Financial Officer

Fenwal recebe aprovação da FDA para troca terapêutica de plasma no seu separador Amicus®

Cannabis Science Continues Forward with FDA IND Process as Patients Report Successful Cancer Treatments

Riassunto: Fenwal ottiene l'autorizzazione dell'FDA per la plasmaferesi terapeutica per il suo separatore Amicus®

The Multiple Myeloma Research Foundation (MMRF) and Translational Genomics Research Institute Announce Innovative Molecular Profiling and Biobanking Collaboration for Landmark Multiple Myeloma Study
FDA Press Releases
Obama administration takes action to address tobacco epidemic

U.S. Marshals seize unapproved and misbranded drug products at Missouri distributor

FDA pursues enforcement action against California fish processor

FDA to discuss risks and benefits of metal-on-metal hip replacements

FDA approves additional blood test for viruses linked to leukemia, neurologic diseases

 FDA Vaccines, Blood and Biologics - What's New
WinRho SDF Liquid

Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

 FierceBiotech
AstraZeneca pays $50M to partner up on Amgen antibodies

Keryx, Aeterna shares crater on word of Phase III cancer study flop

AstraZeneca pays $50 million to partner up on Amgen antibodies

Novartis posts promising Phase III results for blockbuster hopeful QVA149

Lundbeckfond contributes to $25M B round for AlloCure's Phase II stem cell study
FierceBiotech IT
Check out the new and improved FierceBiotech IT website

Silicon Valley pro studies do-it-yourself clinical trials

NIH grabs share of Obama's new $200M bet on big data

Oracle to snap up clinical study software-maker ClearTrial

Tech startup cuts through social media noise for drug and device outfits

 FierceBiotech Research
New drug blocks brain cancer advance, making chemo kill easier

Researchers coax immature brain stem cells from connective tissue

Protein deficiency a tantalizing key to type 2 diabetes

NEJM: Blame chronic diarrhea on mutated gene

Infant trauma, genetics combine to boost schizophrenia odds

 FiercePharma
GSK's Witty winning at pharma chess in post-blockbuster era

Check out the new and improved FiercePharma.com

An Etch-a-Sketch picture of J&J CEO-to-be Alex Gorsky

Ranbaxy ships Indian-made Lipitor copies to U.S.

Can pricey cancer drugs outlast austerity
FiercePharma Manufacturing
Sandoz Canada president explains shortages to House of Commons

Halo agrees to buy Teva's Montreal facility

Novartis plant disruptions affect pet treatments

CMC, third-party manufacturing issues delay Map drug launch

California implant makers get FDA warnings

 FierceVaccines
UPDATED: Academics' oral stomach flu vax could save lives

Study: No benefit for Merck's zoster booster

Gardasil could cut cancer in women already infected with HPV

Genetic tweaking could create chlamydia vaccine

Narcolepsy spike linked with flu shot

 Health News - BizJournals.com
Amgen, AstraZeneca team up for drug development

Docs IBC cost-incentive program paid out $37M

Amazon, Microsoft in top 10 of Brand Excellence Awards

Patterson buys Surgical Synergies, distributor of rehab and mobility products

San Antonio's blood bank establishes nonprofit holding company
Health News - CNBC
Apple, Avon, Express Scripts are market movers

Amgen and AstraZeneca strike $50M deal

Obama takes a shot at Supreme Court over healthcare

Amgen, Astra to collaborate on several drugs

Obama confident Supreme Court will uphold healthcare law

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
AlloCure Pockets $25M for Acute Kidney Injury Stem Cell Therapy

More Than Half the Respondents to a GEN Poll Support a Ban on Chimps in Research

Ingenuity, Life Tech Introduce Solution for Real-Time PCR Gene-Expression Analysis

Report Urges EU Nations to Boost R&D Through Tax, Regulatory Policies

Amylin Pharmaceuticals, Inc. and Illumina, Inc. Benefit From JOBS Act
Marketwire - Pharma and Biotech
AVID Bioservices Highlights Antibody Engineering, Expression and Bioassay Expertise at AACR

Boston Therapeutics Corporate Update

NuPathe to Present at the 11th Annual Needham Healthcare Conference

Osta Biotechnologies Experiencing Financial Constraints

Theratechnologies annoncera ses rltats financiers du premier trimestre de 2012

 MassBio News
Norton High School Named MassBioEd Innovative School of the Year

Vertex Founder Joshua Boger to Receive MassBio's Henri Termeer Innovative Leadership Award

MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

 Medical Pharma - PR Newswire
Keep Kids on the Field and Out of the Operating Room

Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio

Sigma-Aldrich Acquires Research Organics to Strengthen Portfolio of PharmaGrade Raw Materials

TeamHealth Enters Into Strategic Marketing Alliance With Specialists On Call

Washington State Changes Course - Upholds Prudent Layperson Standard for Medicaid Emergency Patients
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
Know before you go

Confronting the Gordian knot

Agbiotech 2.0

Tiptoeing around transgenics

Mission Therapeutics

 New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge
New York Times- Pharmaceuticals
Panel Recommends More Testing for Obesity Drugs

The Place to Head Off Malaria

Judge Bars Imported Drugs in Executions

Amgen Loses Monopoly on Drug for Dialysis Patients

Drug to Cut Cholesterol Level Tests Better Than Statins

 OnBioVC
1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

 Outsourcing-Pharma
Comparator sourcing is a complex challenge in a globalised market says Clinigen

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

European CMO market will double in just 6 years, says Frost & Sullivan

Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert
Pharma News - Business Wire
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2012 Fourth Quarter Earnings

Adimab Completes Series F Financing - Acquires New Research Facility to Accommodate Growth

2011 : Année de transition pour Cegedim - Retour à la croissance attendu en 2012

Research and Markets: The 2012 European Clinical Chemistry and Immunodiagnostics Markets: France, Germany, Italy, Spain and UK Report Profiles key Competitors

Washington Biotechnology & Biomedical Association Announces Dates for Life Science Innovation Northwest 2012

 Pharma News - PharmiWeb
First Global Social Giving Campaign "Everyone Gives" Makes Its Mark

NACDS, NCPA Comment on FTC Conclusion of Express Scripts-Medco Merger Review

Harmful Mega-PBM Merger Must Be Stopped

The ActiViews CT-Guide Navigation System Named as Finalist in the 2012 Medical Design Excellence Awards

GLP-1R Agonist Market Review by La Merie Most Recently Published at MarketPublishers.com

 Pharma News - PR Newswire
Sunpeaks Ventures Announces Strategic Sales and Marketing Agreement with Acosta

Law Office of Brodsky & Smith, LLC Announces Investigation of ISTA Pharmaceuticals, Inc.

Gerresheimer Grows in the Emerging Markets and Acquires Indian Pharma Glass Manufacturer Neutral Glass

Prasco Launches Authorized Generic Nisoldipine Extended Release Tablets

Hospira to Host Conference Call for First-quarter 2012 Results
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

 PRWeb - Biotechnology
Cayman Enterprise City Signs Strategic Partnership with Dubai Multi...

Global Cell-Based Assays Market to Exceed $1.5 Billion by 2017,...

Hudson Valley Orthopaedic Surgeon Dedicates Time in Haiti

DecomWorld: Well Plugging and Abandonment: Trends, Innovations and...

Nuclear Energy Insider: Exelon, Progress Energy and TVA in crucial...
PRWeb - Pharmaceuticals
Compassion Tea Company Announces Website Launch to Share Teas, Save...

Generic Medicines and Coupons Provide Dual Savings from Big Mountain...

Remove Lines, Lift Sags, Lighten Blemishes and Look 5 Years Younger -...

New Study Reveals Paxil During Pregnancy Increases Risk of...

US Drug Watchdog Now Offers to Assist All Woman Who Used the...

 Scientific American
How Useful Is Whole Genome Sequencing to Predict Disease

World Repository of Human Genetics Will Move to Amazon's Cloud

A Tour of the New Geopolitics of Global Warming

The New Geopolitics of Global Warming

U.S. Military Forges Ahead with Plans to Combat Climate Change

 Sports - ESPN Basketball
UNC's Marshall takes Cousy Award as top PG

Kentucky police: No tolerance for unruly fans

Ex-Rhode Island coach Baron hired at Canisius

Mississippi St. introduces ex-Clemson aide Ray

Texas' Brown to skip senior season for draft
Sports News - ESPN
Sources: Petrino suffered broken ribs in crash

Sources: Petrino 'pretty banged up' in crash

Arkansas' Petrino involved in motorcycle crash

Longhorns' Brown remains mum on starting QB

Texas unveils Ricky Williams statue at stadium

 Xconomy Life Sciences
AVI Biopharma Passes Small Study in Muscular Dystrophy

San Diego's Sapphire Energy Raises $144M for Green Crude Farm

Xconomy Boston's Top 20 Stories of Q1: Editor's Picks

Biotech Cant Sidestep Cost-Effectiveness Anymore

Genentech, ImmunoGen 'smart Bomb for Breast Cancer Clears Big Hurdle

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012